Abdominal Inflammatory Myofibroblastic Tumor in an Infant: a Case Report

Abstract

Inflammatory myofibroblastic tumor is a rare neoplasm of childhood with uncertain biological potential. In more than half of the cases, inflammatory myofibroblastic tumor pathogenesis is associated with ALK gene translocations. The standard treatment is radical surgical treatment. In patients with inoperable, recurrent, or metastatic forms of the disease—which are extremely rare—therapeutic options remain very limited. This article presents a case report of an 8-month-old patient diagnosed with an abdominal inflammatory myofibroblastic tumor. The abdominal mass was initially noticed by the parents. No specific clinical symptoms were observed. Upon examination at the clinic, a multinodular mass was localized to the omentum, ascending colon, and parietal peritoneum. Magnetic resonance imaging and abdominal ultrasound were used as the primary diagnostic modalities during the preoperative stage. Blood tests, including clinical and biochemical parameters, showed no significant abnormalities, and tumor markers were negative. Surgical treatment was indicated due to the presence of a large abdominal mass, with its topography confirmed by contrast-enhanced magnetic resonance imaging angiography. A median laparotomy was performed, followed by tumor excision, subtotal omentectomy, resection of the ascending colon, and colo-colonic anastomosis. The postoperative course was uneventful. The outcome was full recovery. The presented case of an abdominal inflammatory myofibroblastic tumor highlights the need to include this tumor type in the differential diagnosis of abdominal masses in young children. A notable feature of this case is the asymptomatic course and the radical excision of multiple nodules with varying locations, which serves as a predictor of favorable prognosis. No additional therapy was required due to the completeness of surgical treatment.

Keywords

inflammatory multinodular myofibroblastic tumor / children / abdominal cavity / surgical treatment / case report

References

[1] Suleymanova AM, Kachanov DYu, Imyanitov EN, et al. Inflammatory myofibroblastic tumors in children: literature review. Russian Journal of Pediatric Hematology and Oncology. 2020;7(2):64–77. doi: 10.21682/2311-1267-2020-7-2-64-77 EDN: CSEPBX

[2] Kachanov DYu, Shamanskaya TV, Suleymanova AM, et al. Inflammatory myofibroblastic tumor of the small bowel mesentery complicated by the intestinal obstruction. Pediatric Hematology/Oncology and Immunopathology. 2017;16(1):54–61. doi: 10.24287/1726-1708-2017-16-1-54-61 EDN: YRWWRH

[3] Zhu X, Chen W-B, Xing F-B, et al. Treatment, pathological characteristics, and prognosis of pulmonary inflammatory myofibroblastic tumor — a retrospective study of 8 cases. Front Oncol. 2022;12:840886. doi: 10.3389/fonc.2022.840886

[4] Venina AR, Preobrazhenskaya EV, Suleymanova AM, et al. Spectrum of genetic rearrangements in an expanded sample of inflammatory myofibroblastic tumors in children. Problems in oncology. 2023;69(3S):306–308. EDN: QSLILI (In Russ.)

[5] Yunusova YuR, Fedorina TA, Rozumny DV, Shamin AV. Morphological features of the inflammatory myofibroblastic tumor. Science and innovations in medicine. 2018;(2):60–65. EDN: UTLICY

[6] Suleymanova AM, Filin AV, Kachanov DYu, et al. Case report of the inflammatory myofibroblastic tumor of the liver in infant. Pediatric Hematology/Oncology and Immunopathology. 2018;17(3):93–102. doi: 10.24287/1726-1708-2018-17-3-93-102 EDN: XZTXNR

[7] Kozhevnikov VA, Yelkova DA. Inflammatory myofibroblastic lung tumor in children. Russian Pediatric Journal. 2022;3(1):149. EDN: GZZHCR

[8] Bai Y-F, Liu J-Z, Yue L-N, et al. Child inflammatory myofibroblastic tumor of the kidney misdiagnosed as Wilms’ tumor: case report. Radiol Case Rep. 2022;17(12):4920–4923. doi: 10.1016/j.radcr.2022.09.079

[9] Domínguez-Massa C, Doñate-Bertolín L, Blanco-Herrera ÓR, et al. Inflammatory myofibroblastic tumor: A rare entity with a complex diagnosis. Revista Portuguesa de Cardiologia. 2023;42(2):169.e1–169.e4. doi: 10.1016/j.repc.2022.12.007

[10] Nakarmi R, Chen M-j, Ong K-H, et al. Inflammatory myofibroblastic tumor: A rare case. NMCJ. 2021;23(4):360–364. doi: 10.3126/nmcj.v23i4.42279

[11] Musaelyan AA, Ustyuzhaninov AS, Urtenova, MA, et al. Ten-year response to crizotinib in ALK-positive inflammatory myofibroblastic tumors: Case reports. Problems in oncology. 2024;70(2):384–389. doi: 10.37469/0507-3758-2024-70-2-384-389 EDN: JSWUFT

[12] Nikolaeva SA, Egorova VB, Kondratyeva SA, et al. A rare case of inflammatory myofibroblastic abdominal tumor in a child. Yakut Medical Journal. 2024;(1):133–135. doi: 10.25789/YMJ.2024.85.34 EDN: FJIWVG

[13] Stalmakhovich VN, Kaygorodova IN, Li IB, et al. Inflammatory myofibroblastic tumor in children. Russian journal of pediatric surgery. 2021;25(S):284–289. doi: 10.18821/156095102021254284-289 EDN: PFFTKC

[14] Bhalla V, Khalid A, Perez V, et al. Pulmonary inflammatory myofibroblastic tumor. J Bronchol Interv Pulmonol. 2024;31(3):e0963 doi: 10.1097/LBR.0000000000000963

[15] Claramunt Andreu G, Murcia Clemente L, Calzado Agrasot MÁ, Kalbouza Bouziane S. Inflammatory myofibroblastic tumor: An uncommon pathology in pediatrics. Anales de Pediatría (English Edition). 2024;100(1):75–76. doi: 10.1016/j.anpede.2023.12.008

[16] Matos I, do Bom-Sucesso M, Pinto D. Large inflammatory myofibroblastic tumor of the lung in a pediatric patient. Archivos de Bronconeumologia. 2024;60(2):103–104. doi: 10.1016/j.arbres.2023.11.002

[17] Shestakov AL, Charchyan ER, Rykov OV, et al. Surgical treatment of recurrent inflammatory myofibroblastic tumor of the posterior mediastinum (clinical observation). Clinical and experimental surgery. Petrovsky journal. 2014;(4):66–71. EDN: TRLZYD

[18] Khanal N, Subedi R, Shrestha N, Shrestha S. Inflammatory myofibroblastic tumor presenting as ileocolic intussusception: A case report. Clin Case Rep. 2023;11(10):e8064. doi: 10.1002/ccr3.8064

RIGHTS & PERMISSIONS

Eco-Vector